期刊文献+

TRAIL对原代卵巢癌细胞增殖、凋亡及核因子κB的影响 被引量:1

Effects of TRAIL on Proliferation,Apoptosis and NF-κB of Primary Human Ovarian Cancer Cell
暂未订购
导出
摘要 目的观察肿瘤坏死因子相关凋亡诱导配体(TNF-related apoptosis inducing-ligand;TRAIL)对原代卵巢癌细胞生长的抑制和诱导肿瘤细胞凋亡效应,以及细胞核因子κB(NF-κB)激活和转运的影响。方法来源于12例病人原代卵巢癌细胞,给予TRAIL0、5、10、20、50、100μg/L分别作用24、48、72和96h,运用MTT比色法检测原代卵巢癌细胞生长、增殖情况;细胞免疫荧光法检测原代卵巢癌细胞凋亡和细胞内NF-κB激活-转运情况。结果 TRAIL对原代卵巢癌细胞的生长抑制呈剂量依赖性,浓度大于20μg/L时抑制率增辐减慢;浓度相同时对癌细胞的抑制呈时间依赖性,72h后抑制率上升减缓;肿瘤细胞凋亡率随TRAIL作用时间延长而增加,5μg/L24h、96h凋亡率分别是(28±1.18)%、(55±4.12)%;肿瘤细胞凋亡率也呈剂量依赖性;TRAIL作用后原代卵巢癌细胞质和胞核中NF-κB表达增加。结论 TRAIL抑制原代卵巢癌细胞的增殖和生长,并诱导癌细胞的凋亡;激活癌细胞质中NF-κB向细胞核内转运。 Objective To investigate the regulatory effects of TRAIL on proliferation and apoptosis of primary human ovarian cancer cell in vitro,and the activation and transportation of NF-κB.Methods Primary human ovarian cancer cells were obtained from twelve patients.Each patient's cell was divided to six groups,and treated with TRAIL(5~100μg/L) for 24~96h respectively.The ratio of growth inhibition was measured with MTT in primary human ovarian cancer cells.The ratio of apoptosis and the transportation and activation of NF-κB were measured by immunofluorescence in primary human ovarian cancer cells.Results The ratio of growth inhibition increased in dose-and time-dependent manner when the concentration was 5,10or 20μg/L at 24,48,72h.The ratio of apoptosis increased along with the time lasting.It was(28±1.18)% with concentration of 100μg/L at 24h,and(55± 4.12)%at 96h.The level of NF-κB in nucleus and cytoplasm was highly expressed.Conclusion TRAIL inhibits proliferation and growth of primary human ovarian cancer cell,and induces apoptosis.It enhances conveying the NF-κB from cytolymph to nucleolus.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第11期1296-1299,共4页 Cancer Research on Prevention and Treatment
关键词 原代卵巢癌细胞 肿瘤坏死因子相关凋亡诱导配体 凋亡 核因子ΚB Primary ovarian cancer cells TNF-related apoptosis inducing-ligand Apoptosis NF-κB
  • 相关文献

参考文献10

  • 1司徒镇强,吴军正.细胞培养[M].北京:世界图书出版公司,2004:160-163.
  • 2Thornberry NA, Lazebnik Y. Caspases: enemies within [J]. Science, 1998,281 (5381) : 1312-1316.
  • 3Mongkolsapaya J,Grimes J M, Chen N, et al. Struture of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation[J]. Nat Struct Biol, 1999,6 (11 ): 1048- 1053.
  • 4Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis [J]. Cell, 1997,91 (4) : 443-446.
  • 5Uchida H,Shinoura N,Kitayama J,et al. caspase-8 gene ransduction augments radiation-induced apoptosis in DLD-1 cells [J]. Biochcm Biophys Res Commun, 20112,292 (2) :347-354.
  • 6周莉,丰有吉.重组人TRAIL促卵巢癌细胞凋亡作用的研究[J].中国癌症杂志,2005,15(3):268-270. 被引量:4
  • 7杨彩虹,陈安民,曾恒.肿瘤坏死因子相关凋亡诱导配体对人骨肉瘤的作用[J].肿瘤防治研究,2009,36(5):361-364. 被引量:1
  • 8Ehrhardt H,Fulda S, Schmid I, et al. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappa B[J]. Oneogene, 2003, 22(25) : 3842-3852.
  • 9Sherry S,Gladden JB, Henson ES, et al. Tumor necrosis factor- related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5(DR5) mediated by NF-kappa B activation in epithelial derived cell lines[J]. Apoptosis, 2002,7 (5) : 413-420.
  • 10Ravi R, Bedi GC, Engstrom LW, et al. Regulation of death receptor expression and TRAIL/Apo2L induced apoptosis by NF-kappaB [J]. Nat Cell Biol,2001,3(4) :409-416.

二级参考文献24

  • 1何超,梁建华,胡晓彤,劳伟峰,陈萍.TRAIL基因修饰联合阿霉素对大肠癌细胞株RKO作用的研究[J].中国肿瘤生物治疗杂志,2004,11(2):119-123. 被引量:1
  • 2Schaefer U, Voloshanenko O, Willen D, et al. TRAIL: a multifunctional cytokine [J]. Front Biosci, 2007, 12:3813- 3824.
  • 3Hu H, Jiang C, Schuster T, et al. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway[J]. Mol Cancer Ther,2006,5(7) :1873-1882.
  • 4沈关心,周汝麟.现代免疫学实验技术[M].2版.武汉:湖北科技出版社,2002:514-517.
  • 5Ashkenazi A,Dixit VM Death receptors: signaling and modulation[J]. Science, 1998,281 (5381) : 1305-1308.
  • 6Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAIL induced apoptosis by a family of signaling and decoy receptors[J]. Science,1997 , 277(5327):818-821.
  • 7Hesry V, Piquet-Pellorce C, Travert M, et al. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players[J]. Prostate,2006, 66(9) :987-995.
  • 8Secchiero P, Zerbinati C, di lasio MG, et al. Synergistic cytotoxic activity of recombinanl TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute rnyeloid leukemia cells[J]. Curr Drug Metab,2007,8(4) :395-403.
  • 9Zhang XD, Franco AV, Nguycn T,et al. Differential localization and regulation of death and decoy receptors for TNF-relaled apoptosis-inducing ligand (TRAIL) in human melanoma cells[J]. J Immunol,2000,164(8) :3961-3970.
  • 10Lee SH, Shin MS, Kim HS,et al. Alterations of DR5/TRAIL receptor 2 gene in non-small cell lung cancers[J]. Cancer Res, 1999, 59(22) :5683-5686.

共引文献32

同被引文献13

  • 1李奇志,姜艳娥,张胜名,毛永荣,刘铭球,吴昌鸣,李蓓云.非小细胞肺癌组织中NF-kB和c-myc及p73的表达与意义[J].中华肿瘤防治杂志,2007,14(5):324-327. 被引量:9
  • 2桑崇铃,李强.NF-κB及其与肺癌关系的研究进展[J].中国实用内科杂志,2007,27(16):1313-1315. 被引量:3
  • 3周锡良生物化学,全国高等医学院校统编教材[M].7版,北京:人民卫生出版社,2010:386-387.
  • 4OiXiao F, Wen SL. The prevention of Bmzopyrene Induced Rat's Lung Cancer by EGCGand Its #eehanism, 2010 International Conference on Integrative Medicine against Cancer[ G] ,2010:59.
  • 5Voortman J, Checinska A, Giaccone G. The Proteasomal and apoptotic phenotype determine bortezoaibsen sensitity of NSCLC [ J ]. Mol Cancer, 2007,6:3001 - 3006.
  • 6Davies AM, lara PN, Jrmack PC. Incorporatingbortezomib into the treatment of lung[J]. Clin Cancer Rese,2007,15 : 181 - 183.
  • 7Ougolkov AV,Bone ND,Ferandez-Zapieo ME,et al. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B ceils [ J ]. Blood,2007,110:735 - 742.
  • 8Ikebe M, Kitaura Y, Nakamura M, et al. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/ MyD88 signaling pathway [ J ]. J Surg Oncol, 2009,100:725 - 731.
  • 9Szajnlk M, Szczepanskl M J, Czystowska M, et al. TLR4sigaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer[ J ]. Oncogene,2009,28:4353 - 4363.
  • 10Einspahr JG, Bowen GT, Albets DS, et al. Cross-validation of murine UV signal transduction pathways in human skin[ J]. Photochem Photobi- ol,2008,84:463 - 476.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部